Shinichiro Ohshimo Selected Research

Respiratory Insufficiency (Respiratory Failure)

8/2023	Continuous positive airway pressure versus high-flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial.
6/2023	Medical equipment that improve safety and outcomes of inter-facility transportation of critically ill patients: A systematic review.
7/2022	ARDS Clinical Practice Guideline 2021.
7/2022	ARDS clinical practice guideline 2021.
2/2022	Pulmonary Alveolar Proteinosis with Severe Respiratory Failure Improved by Segmental Lung Lavage with Fiberoptic Bronchoscopy under General Anesthesia.
1/2018	Comparison of extracorporeal membrane oxygenation outcome for influenza-associated acute respiratory failure in Japan between 2009 and 2016.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinichiro Ohshimo Research Topics

Disease

16	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2021 - 12/2005
15	COVID-19 01/2024 - 01/2021
10	Idiopathic Pulmonary Fibrosis 05/2024 - 01/2010
8	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2024 - 12/2018
7	Bronchiectasis 01/2024 - 01/2018
7	Fibrosis (Cirrhosis) 01/2024 - 12/2011
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 06/2008
6	Lung Injury 05/2024 - 12/2019
6	Heart Arrest (Cardiac Arrest) 03/2024 - 01/2019
6	Pneumonia (Pneumonitis) 10/2023 - 03/2022
6	Respiratory Insufficiency (Respiratory Failure) 08/2023 - 01/2018
6	Inflammation (Inflammations) 01/2023 - 11/2016
6	Sepsis (Septicemia) 01/2023 - 12/2017
6	Neoplasms (Cancer) 01/2021 - 09/2008
5	Pulmonary Alveolar Proteinosis 02/2022 - 12/2011
5	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2019 - 11/2012
4	Critical Illness (Critically Ill) 06/2023 - 01/2018
4	Neoplasm Metastasis (Metastasis) 12/2017 - 06/2007
4	Sarcoidosis (Schaumann Disease) 09/2017 - 09/2008
3	Acute Lung Injury 05/2024 - 01/2020
3	Out-of-Hospital Cardiac Arrest 03/2024 - 01/2021
3	Hypoxia (Hypoxemia) 10/2023 - 12/2018
3	Respiratory Sounds (Crackle) 01/2023 - 02/2021
3	Bacterial Pneumonia 07/2022 - 01/2016
3	Tachycardia (Tachyarrhythmias) 01/2022 - 12/2016
3	Patient-Ventilator Asynchrony 08/2021 - 12/2019
3	Lung Neoplasms (Lung Cancer) 10/2020 - 03/2011
3	Disease Progression 01/2020 - 01/2010
3	Syncope (Fainting) 01/2020 - 12/2019
2	Hypercalcemia (Milk Alkali Syndrome) 04/2024 - 03/2011
2	Post-Cardiac Arrest Syndrome 01/2024 - 11/2021
2	postintensive care syndrome 01/2024 - 09/2022
2	Infections 12/2023 - 01/2022
2	Delirium 09/2022 - 08/2021
2	Septic Shock (Toxic Shock Syndrome) 08/2021 - 01/2021
2	Tachypnea 12/2018 - 12/2016
2	Hemorrhage 08/2018 - 12/2012
2	Emphysema 01/2018 - 01/2016
2	Lung Diseases (Lung Disease) 09/2017 - 01/2010
2	Adenocarcinoma of Lung 06/2011 - 06/2007
2	Adenocarcinoma 03/2011 - 06/2007
1	Drowning 04/2024
1	Subcutaneous Emphysema 01/2024
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2024
1	Blau syndrome 10/2023
1	Lung Abscess 05/2023
1	Pleural Empyema (Pyothorax) 05/2023
1	Airway Obstruction (Choking) 01/2023

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 05/2024 - 12/2012
6	Oxygen (Dioxygen)IBA 08/2023 - 12/2019
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2011
5	LigandsIBA 01/2021 - 01/2016
5	Mucin-1 (CA 15-3 Antigen)IBA 12/2017 - 12/2005
3	Bleomycin (Blenoxane)FDA LinkGeneric 05/2024 - 01/2021
3	SteroidsIBA 10/2023 - 07/2022
3	ProcalcitoninIBA 07/2022 - 12/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2017
3	ErbB Receptors (EGF Receptor)IBA 05/2021 - 06/2008
3	AntigensIBA 01/2019 - 11/2012
3	AntibodiesIBA 01/2019 - 06/2007
2	Glycoproteins (Glycoprotein)IBA 05/2024 - 06/2007
2	EnzymesIBA 01/2023 - 12/2018
2	Interferon Type IIBA 10/2022 - 03/2022
2	AutoantibodiesIBA 10/2022 - 03/2022
2	C-Reactive ProteinIBA 07/2022 - 07/2022
2	Interleukin-18 (Interleukin 18)IBA 01/2021 - 01/2010
2	HMGB1 Protein (HMG1)IBA 10/2020 - 01/2020
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019 - 12/2018
2	ChemokinesIBA 01/2019 - 01/2010
2	Receptor for Advanced Glycation End ProductsIBA 11/2017 - 01/2017
2	ChitinasesIBA 10/2017 - 01/2017
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2016 - 01/2014
2	Surface-Active Agents (Surfactants)IBA 04/2013 - 12/2011
2	alpha-Methyltyrosine (Metirosine)FDA Link 08/2010 - 09/2008
1	Lipocalin-2IBA 05/2024
1	CalciumIBA 04/2024
1	paquinimodIBA 01/2024
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023

Therapy/Procedure

19	Extracorporeal Membrane Oxygenation 10/2023 - 01/2015
14	Artificial Respiration (Mechanical Ventilation) 01/2024 - 01/2018
11	Therapeutics 12/2023 - 06/2011
7	Traction 01/2024 - 01/2018
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2011
5	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2023 - 02/2021
5	Cannula 08/2023 - 02/2021
4	Resuscitation 03/2024 - 01/2019
4	Induced Hypothermia 01/2024 - 12/2019
3	Cardiopulmonary Resuscitation (CPR) 03/2024 - 12/2019
3	Critical Care (Surgical Intensive Care) 01/2024 - 01/2021
3	Mechanical Ventilators (Ventilator) 06/2023 - 02/2021
3	First Aid (Aids, First) 01/2020 - 12/2019
2	Nutrition Therapy (Medical Nutrition Therapy) 01/2024 - 01/2022
2	Continuous Positive Airway Pressure 08/2023 - 12/2018
2	Respiratory Therapy (Therapy, Respiratory) 07/2022 - 07/2022
2	Length of Stay 01/2022 - 01/2022
1	Renal Dialysis (Hemodialysis) 04/2024
1	Terminal Care (Care, Terminal) 03/2024
1	Anesthesia 01/2023
1	Punctures 01/2023